Literature DB >> 24737483

PAX6, a novel target of miR-335, inhibits cell proliferation and invasion in glioma cells.

Quan Cheng1, Hui Cao2, Zigui Chen1, Zhiming Ma1, Xin Wan1, Renjun Peng1, Bing Jiang1.   

Abstract

Paired box 6 (PAX6), a highly conserved transcription factor, is important in glioma. However, the molecular mechanisms involved remain unclear. The present study demonstrated that the expression of PAX6 was significantly reduced with the malignancy of glioma and also identified PAX6 as a novel target of microRNA (miR)‑335, which was significantly upregulated in glioma. The inhibition of miR‑335 increased the protein expression of PAX6, whereas the upregulation of miR‑335 suppressed its expression in human glioma U251 and U87 cells. Furthermore, upregulation of miR-335 promoted U251 cell proliferation, colony formation and invasion, which was reversed by the overexpression of PAX6. Furthermore, the present study demonstrated that the effect of miR‑335 on U251 cell invasion was via the modulation of matrix metalloproteinase (MMP)‑2 and MMP‑9 expression by targeting PAX6. In conclusion, the present study demonstrated that PAX6, as a novel target of miR‑335, has an anti‑oncogenic function in glioma, and thus PAX6 may serve as a therapeutic target for glioma.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24737483     DOI: 10.3892/mmr.2014.2150

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  14 in total

Review 1.  Understanding the CREB1-miRNA feedback loop in human malignancies.

Authors:  Ya-Wen Wang; Xu Chen; Rong Ma; Peng Gao
Journal:  Tumour Biol       Date:  2016-04-09

2.  MicroRNA-130a inhibits cell proliferation, invasion and migration in human breast cancer by targeting the RAB5A.

Authors:  Yuanqing Pan; Renjie Wang; Fengwa Zhang; Yonglin Chen; Qingfang Lv; Ge Long; Kehu Yang
Journal:  Int J Clin Exp Pathol       Date:  2015-01-01

3.  [Construction of a lentiviral vector carrying short?hairpin RNA targeting PAX6 and its effect on proliferation of glioma U251 cells in vitro].

Authors:  Xiao-Hong Liao; Wei-Lan Yin; Fang Wang; Li-Xiang Wu; Bai-Sheng Huang
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2017-12-20

4.  MicroRNA-375 targets PAX6 and inhibits the viability, migration and invasion of human breast cancer MCF-7 cells.

Authors:  Qiongyan Zou; Wenjun Yi; Jianghai Huang; Fenfen Fu; Gannong Chen; Dewu Zhong
Journal:  Exp Ther Med       Date:  2017-06-13       Impact factor: 2.447

Review 5.  Diverse roles of miR-335 in development and progression of cancers.

Authors:  Long-Ji Luo; Dan-Dan Wang; Jing Wang; Fan Yang; Jin-Hai Tang
Journal:  Tumour Biol       Date:  2016-10-08

6.  Inhalational Anesthetics Inhibit Neuroglioma Cell Proliferation and Migration via miR-138, -210 and -335.

Authors:  Masashi Ishikawa; Masae Iwasaki; Hailin Zhao; Junichi Saito; Cong Hu; Qizhe Sun; Atsuhiro Sakamoto; Daqing Ma
Journal:  Int J Mol Sci       Date:  2021-04-21       Impact factor: 5.923

7.  The Oncogenic Response to MiR-335 Is Associated with Cell Surface Expression of Membrane-Type 1 Matrix Metalloproteinase (MT1-MMP) Activity.

Authors:  Fausto Rojas; Maria E Hernandez; Milagros Silva; Lihua Li; Subbaya Subramanian; Michael J Wilson; Ping Liu
Journal:  PLoS One       Date:  2015-07-23       Impact factor: 3.240

8.  Loss-of-function screening to identify miRNAs involved in senescence: tumor suppressor activity of miRNA-335 and its new target CARF.

Authors:  Yue Yu; Ran Gao; Zeenia Kaul; Ling Li; Yoshio Kato; Zhenya Zhang; Joanna Groden; Sunil C Kaul; Renu Wadhwa
Journal:  Sci Rep       Date:  2016-07-26       Impact factor: 4.379

Review 9.  MicroRNAs in glioblastoma multiforme pathogenesis and therapeutics.

Authors:  Amanda Shea; Varsha Harish; Zainab Afzal; Juliet Chijioke; Habib Kedir; Shahnoza Dusmatova; Arpita Roy; Malathi Ramalinga; Brent Harris; Jan Blancato; Mukesh Verma; Deepak Kumar
Journal:  Cancer Med       Date:  2016-06-10       Impact factor: 4.452

10.  Generation of a PAX6 knockout glioblastoma cell line with changes in cell cycle distribution and sensitivity to oxidative stress.

Authors:  Beate Hegge; Eva Sjøttem; Ingvild Mikkola
Journal:  BMC Cancer       Date:  2018-05-02       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.